Roy L. Harris

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Cereblon binding compounds, compositions thereof, and methods of tr...
- Patent number 12,103,920
- Issue date Oct 1, 2024
- Celgene Corporation
- Matthew D. Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 4-aminoisoindoline-1,3-dione compounds, compositions th...
- Patent number 11,945,804
- Issue date Apr 2, 2024
- Celgene Corporation
- Matthew D. Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cereblon binding compounds, compositions thereof, and methods of tr...
- Patent number 11,739,075
- Issue date Aug 29, 2023
- Celgene Corporation
- Matthew D. Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cereblon binding compounds, compositions thereof, and methods of tr...
- Patent number 11,634,407
- Issue date Apr 25, 2023
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cereblon binding compounds, compositions thereof, and methods of tr...
- Patent number 11,560,371
- Issue date Jan 24, 2023
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted 4-aminoisoindoline-1,3-dione compounds, compositions th...
- Patent number 11,358,952
- Issue date Jun 14, 2022
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
- Patent number 11,292,796
- Issue date Apr 5, 2022
- Signal Pharmaceuticals, LLC
- Jan Elsner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
- Patent number 10,683,298
- Issue date Jun 16, 2020
- Signal Pharmaceuticals, LLC
- Jan Elsner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
- Patent number 10,167,290
- Issue date Jan 1, 2019
- Signal Pharmaceuticals, LLC
- Jan Elsner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolopyrimidine compounds, compositions thereof, and...
- Patent number 9,795,607
- Issue date Oct 24, 2017
- Signal Pharmaceuticals, LLC
- Andrew Antony Calabrese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
- Patent number 9,771,371
- Issue date Sep 26, 2017
- Signal Pharmaceuticals, LLC
- Jan Elsner
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolopyrimidine compounds, compositions thereof, and...
- Patent number 9,428,509
- Issue date Aug 30, 2016
- Signal Pharmaceuticals, LLC
- Andrew Antony Calabrese
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolopyrimidine compounds, compositions thereof, and...
- Patent number 9,346,812
- Issue date May 24, 2016
- Signal Pharmaceuticals, LLC
- Andrew Antony Calabrese
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Halogen substituted pyrazines as intermediates of mTOR kinase inhib...
- Patent number 9,193,692
- Issue date Nov 24, 2015
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of synthesis and purification of heteroaryl compounds
- Patent number 9,079,900
- Issue date Jul 14, 2015
- Signal Pharmaceuticals, LLC
- Roy L. Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors
- Patent number 8,907,087
- Issue date Dec 9, 2014
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of synthesis and purification of heteroaryl compounds
- Patent number 8,569,494
- Issue date Oct 29, 2013
- Signal Pharmaceuticals, LLC
- Roy L. Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indicati...
- Patent number 8,507,492
- Issue date Aug 13, 2013
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indicati...
- Patent number 8,492,381
- Issue date Jul 23, 2013
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treatment comprising the administration of heteroaryl co...
- Patent number 8,372,976
- Issue date Feb 12, 2013
- Signal Pharmaceuticals, LLC
- Deborah Sue Mortensen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indicat...
- Patent number 8,110,578
- Issue date Feb 7, 2012
- Signal Pharmaceuticals, LLC
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...
- Publication number 20240374591
- Publication date Nov 14, 2024
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...
- Publication number 20240368118
- Publication date Nov 7, 2024
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS, COMPOSITIONS TH...
- Publication number 20240217955
- Publication date Jul 4, 2024
- Celgene Corporation
- Matthew D. Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...
- Publication number 20230242509
- Publication date Aug 3, 2023
- Ceigene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20230119470
- Publication date Apr 20, 2023
- Signal Pharmaceuticals, LLC.
- Jan ELSNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS, COMPOSITIONS TH...
- Publication number 20220306611
- Publication date Sep 29, 2022
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...
- Publication number 20220002273
- Publication date Jan 6, 2022
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...
- Publication number 20210403454
- Publication date Dec 30, 2021
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...
- Publication number 20210403453
- Publication date Dec 30, 2021
- Celgene Corporation
- Matthew D. Alexander
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20200262840
- Publication date Aug 20, 2020
- Signal Pharmaceuticals, LLC.
- Jan ELSNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS, COMPOSITIONS TH...
- Publication number 20190322647
- Publication date Oct 24, 2019
- Celgene Corporation
- Matthew D. Alexander
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20190077806
- Publication date Mar 14, 2019
- Signal Pharmaceuticals, LLC.
- Jan ELSNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20170342080
- Publication date Nov 30, 2017
- Signal Pharmaceuticals, LLC.
- Jan ELSNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF, AND...
- Publication number 20160324861
- Publication date Nov 10, 2016
- Signal Pharmaceutical, LLC
- Andrew Antony Calabrese
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20160024101
- Publication date Jan 28, 2016
- Signal Pharmaceuticals, LLC.
- Jan ELSNER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20150051397
- Publication date Feb 19, 2015
- Signal Pharmaceuticals, LLC.
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF, AND...
- Publication number 20140200207
- Publication date Jul 17, 2014
- Signal Pharmaceutical LLC
- Andrew Antony Calabrese
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF, AND...
- Publication number 20140200206
- Publication date Jul 17, 2014
- Signal Pharmaceutical LLC
- Andrew Antony Calabrese
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS
- Publication number 20140155593
- Publication date Jun 5, 2014
- Signal Pharmaceuticals, LLC.
- Roy L. Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...
- Publication number 20130289271
- Publication date Oct 31, 2013
- Signal Pharmaceuticals, LLC.
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS
- Publication number 20130245254
- Publication date Sep 19, 2013
- Signal Pharmaceuticals, LLC.
- Roy L. Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATI...
- Publication number 20120071658
- Publication date Mar 22, 2012
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATI...
- Publication number 20120059164
- Publication date Mar 8, 2012
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS
- Publication number 20110137028
- Publication date Jun 9, 2011
- Roy L. Harris
- C07 - ORGANIC CHEMISTRY
Information Patent Application
mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCI...
- Publication number 20100216781
- Publication date Aug 26, 2010
- Sophie Perrin-Ninkovic
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Amino-substituted heterocycles, compositions thereof, and methods o...
- Publication number 20080242694
- Publication date Oct 2, 2008
- Neil R. D'Sidocky
- C07 - ORGANIC CHEMISTRY

Roy L. Harris

Person

Patents Grantslast 30 patents

Cereblon binding compounds, compositions thereof, and methods of tr...

Substituted 4-aminoisoindoline-1,3-dione compounds, compositions th...

Cereblon binding compounds, compositions thereof, and methods of tr...

Cereblon binding compounds, compositions thereof, and methods of tr...

Cereblon binding compounds, compositions thereof, and methods of tr...

Substituted 4-aminoisoindoline-1,3-dione compounds, compositions th...

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Substituted pyrrolopyrimidine compounds, compositions thereof, and...

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Substituted pyrrolopyrimidine compounds, compositions thereof, and...

Substituted pyrrolopyrimidine compounds, compositions thereof, and...

Halogen substituted pyrazines as intermediates of mTOR kinase inhib...

Methods of synthesis and purification of heteroaryl compounds

Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors

Methods of synthesis and purification of heteroaryl compounds

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indicati...

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indicati...

Methods of treatment comprising the administration of heteroaryl co...

Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indicat...

Patents Applicationslast 30 patents

CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...

CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...

SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS, COMPOSITIONS TH...

CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS, COMPOSITIONS TH...

CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...

CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...

CEREBLON BINDING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TR...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

SUBSTITUTED 4-AMINOISOINDOLINE-1,3-DIONE COMPOUNDS, COMPOSITIONS TH...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF, AND...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF, AND...

SUBSTITUTED PYRROLOPYRIMIDINE COMPOUNDS, COMPOSITIONS THEREOF, AND...

METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITORS FOR ONCOLOGY INDICAT...

METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATI...

PYRAZINO[2,3-b]PYRAZINE mTOR KINASE INHIBITOR FOR ONCOLOGY INDICATI...

METHODS OF SYNTHESIS AND PURIFICATION OF HETEROARYL COMPOUNDS

mTOR KINASE INHIBITORS FOR ONCOLOGY INDICATIONS AND DISEASES ASSOCI...

Amino-substituted heterocycles, compositions thereof, and methods o...